Why InvoCare and these ASX shares just stormed to 52-week highs

The InvoCare Limited (ASX:IVC) share price is one of three charging to new highs this week. Here's why…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

a woman

The Australian share market has been on fire this month, rising to a multi-year high thanks partly to the Federal election result.

Unsurprisingly, this has led to a number of shares storming to 52-week highs or better. Three that achieved this are listed below. Here's why they are flying high:

The Audinate (ASX: AD8) share price reached an all-time high of $7.49 on Wednesday. Investors have been fighting to get hold of the shares of the leading provider of digital Audio-Visual networking technologies due to the success of its Dante audio over IP networking solution. Dante is an uncompressed, multi-channel digital media networking technology, with near-zero latency and synchronisation. The quality of the product has led to Dante quickly becoming the industry's preferred audio networking solution. At the last count the product had been adopted by more pro-audio AV manufacturers than any other networking technology.

The InvoCare Limited (ASX: IVC) share price climbed to a 52-week high of $16.08 yesterday. The funerals company's shares have been on a solid run since the release of first quarter update earlier this month which revealed that trading conditions have improved this year. In addition to this, a particularly severe flu season appears to have caught the eye of investors and could (unfortunately) mean increased demand for its funeral services.

The Next Science Ltd (ASX: NXS) share price raced to a new all-time high of $2.49 on Wednesday. This means that the recently listed medical technology company's shares have risen 149% since hitting the ASX boards at $1.00 per share last month. Investors appear to believe that the company's chronic wound treatment technology has a lot of potential. Next Science has four FDA cleared products currently available in the U.S. market to treat and manage surgical site infections and chronic wounds.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended AUDINATEGL FPO. The Motley Fool Australia has recommended InvoCare Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on 52-Week Highs

Man smiling on top of rocks with mountains in the background.
52-Week Highs

What are brokers saying about these ASX shares hitting 52-week highs

Can these shares keep rising?

Read more »

Three climbers scramble up a rocky peak overlooking a vast snow covered mountain range with an icy blue sky beyond them.
52-Week Highs

What are experts saying about these red hot ASX 200 shares?

These stocks are soaring right now.

Read more »

A man sits on a bench atop a mountain with a laptop, making investments with a green ESG mind.
52-Week Highs

Are these ASX stocks hitting 52-week highs a buy, hold, or sell?

Can these market winners keep rallying?

Read more »

A beautiful ocean vista is shown with a woman whose back is to the camera holding her arms up in triumph as she stands at the top of a rock feeling thrilled that ASX 200 shares are reaching multi-year high prices today
52-Week Highs

3 ASX 200 titans charging to new one-year-plus highs today

Investors just sent these three ASX 200 titans surging to new 52-week-plus highs. But why?

Read more »

Businessman smiles with arms outstretched after receiving good news.
52-Week Highs

Why this reliable ASX dividend stock just climbed to a fresh multi-year high

This ASX dividend stock just touched its highest level since 2023.

Read more »

green arrow rising from within a trolley.
Defensive Shares

Woolworths' $37 share price is near an all-time high, so why am I going to buy some as soon as possible?

Why I still see Woolworths shares as a buy despite trading near all-time highs.

Read more »

A kid and his grandad high five after a fun game of basketball.
52-Week Highs

Telstra just hit a 10-year high. Has this ASX income giant still got more to give?

Telstra’s breakout to a multi-year high is turning heads.

Read more »

Two friends giving each other a high five at the top pf a hill.
52-Week Highs

Are these ASX shares hitting 52-week highs still worth buying?

Is there any more upside for these stocks?

Read more »